Kalaris Therapeutics, Inc. (KLRS) KPIs and segments
KLRSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.43−0.03 (-2.05%)
Close on Nov 17, 2026Market cap $34.04MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Kalaris Therapeutics's business
Coming soon
This tab will track the numbers specific to Kalaris Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?